Olfactory dysfunctions in neurodegenerative disorders

Journal of Neuroscience Research

Volumn 90, Issue 9, 2012, Pages 1693-1700

  Ruan, Yang ^a,b   Zheng, Xiang Yu ^b   Zhang, Hong Liang ^b   Zhu, Wei ^a   Zhu, Jie ^a,b  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Alzheimer's disease; Neurodegeneration; Olfactory dysfunction; Olfactory system; Parkinson's disease

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; TAU PROTEIN;

ALZHEIMER DISEASE; BRAIN DEGENERATION; COGNITIVE DEFECT; DEGENERATIVE DISEASE; DEMENTIA; DISEASE ASSOCIATION; GENETIC RISK; HUMAN; HUNTINGTON CHOREA; LEWY BODY; MILD COGNITIVE IMPAIRMENT; NONHUMAN; OLFACTORY BULB; OLFACTORY DYSFUNCTION; OLFACTORY EPITHELIUM; OLFACTORY NERVE DISEASE; OLFACTORY NUCLEUS; OLFACTORY SYSTEM; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK FACTOR; SHORT SURVEY;

ANIMALS; HUMANS; NEURODEGENERATIVE DISEASES; OLFACTION DISORDERS;

EID: 84863781553     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.23054     Document Type: Short Survey

References (83)

1. Ansari KA, Johnson A. 1975. Olfactory function in patients with Parkinson's disease. J Chronic Dis 28: 493-497.
2. Arnold SE, Lee EB, Moberg PJ, Stutzbach L, Kazi H, Han L-Y, Lee VMY, Trojanowski JQ. 2010. Olfactory epithelium amyloid-β and paired helical filament-tau pathology in Alzheimer disease. Ann Neurol 67: 462-469.
3. Attems J, Jellinger KA. 2006. Olfactory tau pathology in Alzheimer disease and mild cognitive impairment. Clin Neuropathol 25: 265-271.
4. Averback P. 1983. Two new lesions in Alzheimer's disease. Lancet 2: 1203.
5. Bacon AW, Bondi MW, Salmon DP, Murphy C. 1998. Very early changes in olfactory functioning due to Alzheimer's disease and the role of apolipoprotein E in olfaction. Ann N Y Acad Sci 855: 723-731.
6. Barrios FA, Gonzalez L, Favila R, Alonso ME, Salgado PM, Diaz R, Fernandez-Ruiz J. 2007. Olfaction and neurodegeneration in HD. Neuroreport 18: 73-76.
7. Beach TG, White CL, Hladik CL, Sabbagh MN, Connor DJ, Shill HA, Sue LI, Sasse J, Bachalakuri J, Henry-Watson J, Akiyama H, Adler CH. 2009. Olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders. Acta Neuropathol 117: 169-174.
8. Berendse HW, Roos DS, Raijmakers P, Doty RL. 2011. Motor and non-motor correlates of olfactory dysfunction in Parkinson's disease. J Neurol Sci 310: 21-24.
9. Bhatnagar KP, Kennedy RC, Baron G, Greenberg RA. 1987. Number of mitral cells and the bulb volume in the aging human olfactory bulb: a quantitative morphological study. Anat Rec 218: 73-87.
10. Bloch A, Probst A, Bissig H, Adams H, Tolnay M. 2006. Alpha-synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects. Neuropathol Appl Neurobiol 32: 284-295.
11. Boesveldt S, Verbaan D, Knol DL, Visser M, van Rooden SM, van Hilten JJ, Berendse HW. 2008. A comparative study of odor identification and odor discrimination deficits in Parkinson's disease. Mov Disord 23: 1984-1990.
12. Bohnen NI, Gedela S, Herath P, Constantine GM, Moore RY. 2008. Selective hyposmia in Parkinson disease: association with hippocampal dopamine activity. Neurosci Lett 447: 12-16.
13. Bohnen NI, Muller MLTM, Kotagal V, Koeppe RA, Kilbourn MA, Albin RL, Frey KA. 2010. Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson's disease. Brain 133: 1747-1754.
14. Braak H, Del Tredici K, Bratzke H, Hamm-Clement J, Sandmann-Keil D, Rub U. 2002. Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages). J Neurol 249( Suppl 3): III1-III5.
15. Burghaus L, Schütz U, Krempel U, Lindstrom J, Schröder H. 2003. Loss of nicotinic acetylcholine receptor subunits α4 and α7 in the cerebral cortex of Parkinson patients. Parkinsonism Rel Disord 9: 243-246.
16. Buschuter D, Smitka M, Puschmann S, Gerber JC, Witt M, Abolmaali ND, Hummel T. 2008. Correlation between olfactory bulb volume and olfactory function. Neuroimage 42: 498-502.
17. Cassano T, Romano A, Macheda T, Colangeli R, Cimmino CS, Petrella A, LaFerla FM, Cuomo V, Gaetani S. 2011. Olfactory memory is impaired in a triple transgenic model of Alzheimer disease. Behav Brain Res 224: 408-412.
18. Christen-Zaech S, Kraftsik R, Pillevuit O, Kiraly M, Martins R, Khalili K, Miklossy J. 2003. Early olfactory involvement in Alzheimer's disease. Can J Neurol Sci 30: 20-25.
19. Daniel S, Hawkers CH. 1992. Preliminary diagnosis of Parkinson's disease by olfactory bulb pathology. Lancet 340: 186.
20. Devanand DP, Tabert MH, Cuasay K, Manly JJ, Schupf N, Brickman AM, Andrews H, Brown TR, DeCarli C, Mayeux R. 2010. Olfactory identification deficits and MCI in a multi-ethnic elderly community sample. Neurobiol Aging 31: 1593-1600.
21. Djordjevic J, Jones-Gotman M, De Sousa K, Chertkow H. 2008. Olfaction in patients with mild cognitive impairment and Alzheimer's disease. Neurobiol Aging 29: 693-706.
22. Doty RL. 2011. Olfaction in Parkinson's disease and related disorders. Neurobiol Dis (in press).
23. Doty RL, Risser JM. 1989. Influence of the D-2 dopamine receptor agonist quinpirole on the odor detection performance of rats before and after spiperone administration. Psychopharmacology 98: 310-315.
24. Doty RL, Deems DA, Stellar S. 1988. Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology 38: 1237-1244.
25. Doty RL, Stern MB, Pfeiffer C, Gollomp SM, Hurtig HI. 1992. Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 55: 138-142.
26. Duda JE. 2010. Olfactory system pathology as a model of Lewy neurodegenerative disease. J Neurol Sci 289: 49-54.
27. Duda JE, Shah U, Arnold SE, Lee VMY, Trojanowski JQ. 1999. The expression of alpha-, beta-, and gamma-synucleins in olfactory mucosa from patients with and without neurodegenerative diseases. Exp Neurol 160: 515-522.
28. Fernandez-Ruiz J, Díaz R, Hall-Haro C, Vergara P, Fiorentini A, Nunñez L, Drucker-Colín R, Ochoa A, Yescas P, Rasmussen A, Alonso M-E. 2003. Olfactory dysfunction in hereditary ataxia and basal ganglia disorders. Neuroreport 14: 1339-1341.
29. Ferry M. 2005. Strategies for ensuring good hydration in the elderly. Nutr Rev 63: S22-S29.
30. Forster S, Vaitl A, Teipel SJ, Yakushev I, Mustafa M, la Fougere C, Rominger A, Cumming P, Bartenstein P, Hampel H, Hummel T, Buerger K, Hundt W, Steinbach S. 2010. Functional representation of olfactory impairment in early Alzheimer's disease. J Alzheimers Dis 22: 581-591.
31. Gottfried JA, Winston JS, Dolan RJ. 2006. Dissociable codes of odor quality and odorant structure in human piriform cortex. Neuron 49: 467-479.
32. Guérin D, Sacquet J, Mandairon N, Jourdan F, Didier A. 2009. Early locus coeruleus degeneration and olfactory dysfunctions in Tg2576 mice. Neurobiol Aging 30: 272-283.
33. Haehner A, Hummel T, Reichmann H. 2009. Olfactory dysfunction as a diagnostic marker for Parkinson's disease. Expert Rev Neurother 9: 1773-1779.
34. Hawkes CH, Shephard BC, Daniel SE. 1997. Olfactory dysfunction in Parkinson's disease. J Neurol Neurosurg Psychiatry 62: 436-446.
35. Hawkins KA, Pearlson GD. 2011. Age and gender but not common chronic illnesses predict odor identification in older African Americans. Am J Geriatr Psychiatry 19: 777-782.
36. Healy DG, Falchi M, O'sullivan SS, Bonifati V, Durr A, Bressman S, Brice A, Aasly J, Zabetian CP, Goldwurm S, Ferreira JJ, Tolosa E, Kay DM, Klein C, Williams DR, Marras C, Lang AE, Wszolek ZK, Berciano J, Schapira AH, Lynch T, Bhatia KP, Gasser T, Lees AJ, Wood NW. 2008. Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study. Lancet Neurol 7: 583-590.
37. Hower RE, Rick JH, Balderston CC, Weintraub D, Siderowf A, Stern M, Moberg P, Duda J. 2008. Olfactory dysfunction and Parkinson's disease progression. Neurology 70: A397-A398.
38. Hubbard PS, Esiri MM, Reading M, McShane R, Nagy Z. 2007. Alpha-synuclein pathology in the olfactory pathways of dementia patients. J Anat 211: 117-124.
39. Huisman E, Uylings HB, Hoogland PV. 2004. A 100% increase of dopaminergic cells in the olfactory bulb may explain hyposmia in Parkinson's disease. Mov Disord 19: 687-692.
40. Jellinger KA. 2008. A critical reappraisal of current staging of Lewy-related pathology in human brain. Acta Neuropathol 116: 1-16.
41. Jovanovic H, Perski A, Berglund H, Savic I. 2011. Chronic stress is linked to 5-HT1A receptor changes and functional disintegration of the limbic networks. Neuroimage 55: 1178-1188.
42. Kaupp UB. 2010. Olfactory signalling in vertebrates and insects: differences and commonalities. Nat Rev Neurosci 11: 188-200.
43. Kovacs GG, Kloppel S, Fischer I, Dorner S, Lindeck-Pozza E, Birner P, Botefur IC, Pilz P, Volk B, Budka H. 2003. Nucleus-specific alteration of raphe neurons in human neurodegenerative disorders. Neuroreport 14: 73-76.
44. Larsson M, Farde L, Hummel T, Witt M, Lindroth NE, Backman L. 2009. Age-related loss of olfactory sensitivity: association to dopamine transporter binding in putamen. Neuroscience 161: 422-426.
45. Li W, Howard JD, Gottfried JA. 2010. Disruption of odour quality coding in piriform cortex mediates olfactory deficits in Alzheimer's disease. Brain 133: 2714-2726.
46. Makowska I, Kloszewska I, Grabowska A, Szatkowska I, Rymarczyk K. 2011. Olfactory deficits in normal aging and Alzheimer's disease in the Polish elderly population. Arch Clin Neuropsychol 26: 270-279.
47. Meisami E, Mikhail L, Baim D, Bhatnagar KP. 1998. Human olfactory bulb: aging of glomeruli and mitral cells and a search for the accessory olfactory bulb. Ann N Y Acad Sci 855: 708-715.
48. Mesholam RI, Moberg PJ, Mahr RN, Doty RL. 1998. Olfaction in neurodegenerative disease: a meta-analysis of olfactory functioning in Alzheimer's and Parkinson's diseases. Arch Neurol 55: 84-90.
49. Moberg PJ, Pearlson GD, Speedie LJ, Lipsey JR, Strauss ME, Folstein SE. 1987. Olfactory recognition: differential impairments in early and late Huntington's and Alzheimer's diseases. J Clin Exp Neuropsychol 9: 650-664.
50. Morgan CD, Covington JW, Geisler MW, Polich J, Murphy C. 1997. Olfactory event-related potentials: older males demonstrate the greatest deficits. Electroencephalogr Clin Neurophysiol 104: 351-358.
51. Morrison EE, Costanzo RM. 1992. Morphology of olfactory epithelium in humans and other vertebrates. Microsc Res Techniq 23: 49-61.
52. Mouret A, Murray K, Lledo P-M. 2009. Centrifugal drive onto local inhibitory interneurons of the olfactory bulb. Ann N Y Acad Sci 1170: 239-254.
53. Mundiñano I-C, Caballero M-C, Ordóñez C, Hernandez M, DiCaudo C, Marcilla I, Erro M-E, Tuñon M-T, Luquin M-R. 2011. Increased dopaminergic cells and protein aggregates in the olfactory bulb of patients with neurodegenerative disorders. Acta Neuropathol 122: 61-74.
54. Murphy C, Bacon AW, Bondi MW, Salmon DP. 1998. Apolipoprotein E status is associated with odor identification deficits in nondemented older persons. Ann N Y Acad Sci 855: 744-750.
55. Murphy C, Schubert CR, Cruickshanks KJ, Klein BE, Klein R, Nondahl DM. 2002. Prevalence of olfactory impairment in older adults. JAMA 288: 2307-2312.
56. - individuals. Ann N Y Acad Sci 1170: 647-657.
57. Neef D, Walling AD. 2006. Dementia with Lewy bodies: an emerging disease. Am Fam Physician 73: 1223-1229.
58. Nuber S, Petrasch-Parwez E, Arias-Carrion O, Koch L, Kohl Z, Schneider J, Calaminus C, Dermietzel R, Samarina A, Boy J, Nguyen HP, Teismann P, Velavan TP, Kahle PJ, von Horsten S, Fendt M, Kruger R, Riess O. 2011. Olfactory neuron-specific expression of A30P alpha-synuclein exacerbates dopamine deficiency and hyperactivity in a novel conditional model of early Parkinson's disease stages. Neurobiol Dis 44: 192-204.
59. Olichney JM. 2005. Anosmia is very common in the Lewy body variant of Alzheimer's disease. J Neurol Neurosurg Psychiatry 76: 1342-1347.
60. Pearce RK, Hawkes CH, Daniel SE. 1995. The anterior olfactory nucleus in Parkinson's disease. Mov Disord 10: 283-287.
61. Robinson AM, Conley DB, Shinners MJ, Kern RC. 2002. Apoptosis in the aging olfactory epithelium. Laryngoscope 112: 1431-1435.
62. Rogers JD, Brogan D, Mirra SS. 1985. The nucleus basalis of Meynert in neurological disease: a quantitative morphological study. Ann Neurol 17: 163-170.
63. Ross GW, Petrovitch H, Abbott RD, Tanner CM, Popper J, Masaki K, Launer L, White LR. 2008. Association of olfactory dysfunction with risk for future Parkinson's disease. Ann Neurol 63: 167-173.
64. Saunders-Pullman R, Stanley K, Wang C, San Luciano M, Shanker V, Hunt A, Severt L, Raymond D, Ozelius LJ, Lipton RB, Bressman SB. 2011. Olfactory dysfunction in LRRK2 G2019S mutation carriers. Neurology 77: 319-324.
65. Schiffman SS. 1983. Taste and smell in disease (first of two parts). N Engl J Med 308: 1275-1279.
66. Sengoku R, Saito Y, Ikemura M, Hatsuta H, Sakiyama Y, Kanemaru K, Arai T, Sawabe M, Tanaka N, Mochizuki H, Inoue K, Murayama S. 2008. Incidence and extent of Lewy body-related alpha-synucleinopathy in aging human olfactory bulb. J Neuropathol Exp Neurol 67: 1072-1083.
67. Silveira-Moriyama L, Holton JL, Kingsbury A, Ayling H, Petrie A, Sterlacci W, Poewe W, Maier H, Lees AJ, Revesz T. 2009. Regional differences in the severity of Lewy body pathology across the olfactory cortex. Neurosci Lett 453: 77-80.
68. Tillerson JL, Caudle WM, Parent JM, Gong C, Schallert T, Miller GW. 2006. Olfactory discrimination deficits in mice lacking the dopamine transporter or the D2 dopamine receptor. Behav Brain Rese 172: 97-105.
69. Tissingh G, Berendse HW, Bergmans P, DeWaard R, Drukarch B, Stoof JC, Wolters EC. 2001. Loss of olfaction in de novo and treated Parkinson's disease: possible implications for early diagnosis. Mov Disord 16: 41-46.
70. Tsuboi Y, Wszolek ZK, Graff-Radford NR, Cookson N, Dickson DW. 2003. Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein epsilon 4. Neuropathol Appl Neurobiol 29: 503-510.
71. Uchikado H, Lin WL, DeLucia MW, Dickson DW. 2006. Alzheimer disease with amygdala Lewy bodies: a distinct form of alpha-synucleinopathy. J Neuropathol Exp Neurol 65: 685-697.
72. Verbaan D, Boesveldt S, van Rooden SM, Visser M, Marinus J, Macedo MG, Fang Y, Heutink P, Berendse HW, van Hilten JJ. 2008. Is olfactory impairment in Parkinson disease related to phenotypic or genotypic characteristics? Neurology 71: 1877-1882.
73. Wattendorf E, Welge-Lussen A, Fiedler K, Bilecen D, Wolfensberger M, Fuhr P, Hummel T, Westermann B. 2009. Olfactory impairment predicts brain atrophy in Parkinson's disease. J Neurosci 29: 15410-15413.
74. Wenk GL. 2003. Neuropathologic changes in Alzheimer's disease. J Clin Psychiatry 64( Suppl 9): 7-10.
75. Williams SS, Williams J, Combrinck M, Christie S, Smith AD, McShane R. 2009. Olfactory impairment is more marked in patients with mild dementia with Lewy bodies than those with mild Alzheimer disease. J Neurol Neurosurg Psychiatry 80: 667-670.
76. Wilson RS, Arnold SE, Schneider JA, Tang Y, Bennett DA. 2007a. The relationship between cerebral Alzheimer's disease pathology and odour identification in old age. J Neurol Neurosurg Psychiatry 78: 30-35.
77. Wilson RS, Schneider JA, Arnold SE, Tang YX, Boyle PA, Bennett DA. 2007b. Olfactory identification and incidence of mild cognitive impairment in older age. Arch Gen Psychiatry 64: 802-808.
78. Wilson RS, Arnold SE, Schneider JA, Boyle PA, Buchman AS, Bennett DA. 2009. Olfactory impairment in presymptomatic Alzheimer's disease. In: Finger TE, editor. International Symposium on Olfaction and Taste. New York: New York Academy of Sciences. p 730-735.
79. Witt M, Bormann K, Gudziol V, Pehlke K, Barth K, Minovi A, Hähner A, Reichmann H, Hummel T. 2009. Biopsies of olfactory epithelium in patients with Parkinson's disease. Mov Disord 24: 906-914.
80. Wong KK, Muller MLTM, Kuwabara H, Studenski SA, Bohnen NI. 2010. Olfactory loss and nigrostriatal dopaminergic denervation in the elderly. Neurosci Lett 484: 163-167.
81. Wu X, Yu C, Fan F, Zhang K, Zhu C, Wu T, Li K, Chan P. 2011. Correlation between progressive changes in piriform cortex and olfactory performance in early Parkinson's disease. Eur J Neurol 66: 98-105.
82. Yamagishi M, Getchell ML, Takami S, Getchell TV. 1998. Increased density of olfactory receptor neurons immunoreactive for apolipoprotein E in patients with Alzheimer's disease. Ann Otol Rhinol Laryngol 107: 421-426.
83. Zarow C, Lyness SA, Mortimer JA, Chui HC. 2003. Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases. Arch Neurol 60: 337-341.